Kim Kelderman Power - 31 Jul 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Aug 2024, 16:17:04 UTC
Prior SEC filing
05 Feb 2024
Next SEC filing
19 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.

Key filing fact

Kim Kelderman Power filed Form 4 for BIO-TECHNE Corp (TECH) on 02 Aug 2024.

Key facts

  • This page summarizes Kim Kelderman Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 16 derivative rows are listed below.
  • Accepted by SEC: 02 Aug 2024, 16:17.

Change

  • Previous filing in this sequence was filed on 05 Feb 2024.
  • Current net transaction value: -$249,194.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
$527,800
Shares
+14,000
Change %
+40%
Price
$37.70
Shares after
49,421
Date
31 Jul 2024
Ownership
Direct
TECH transaction

Common Stock

Tax liability

Transaction value
$776,994
Shares
-9,479
Change %
-19%
Price
$81.97
Shares after
39,942
Date
31 Jul 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-14,000
Change %
-51%
Price
$0.000000
Shares after
13,392
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,000
Exercise price
$37.70
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
84,308
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
84,308
Exercise price
$44.33
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
109,536
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
109,536
Exercise price
$47.60
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
69,264
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
69,264
Exercise price
$66.97
Footnotes
F1
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
47,952
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,952
Exercise price
$66.97
Footnotes
F2
TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,944
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,944
Exercise price
$120.46
Footnotes
F3
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,984
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,984
Exercise price
Footnotes
F4, F5
TECH holding Derivative

Performance Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,704
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,704
Exercise price
$94.52
Footnotes
F5
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
28,940
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
28,940
Exercise price
$94.52
Footnotes
F6
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,873
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,873
Exercise price
Footnotes
F4, F7
TECH holding Derivative

Performance Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,881
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,881
Exercise price
$84.61
Footnotes
F7
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
29,391
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,391
Exercise price
$84.61
Footnotes
F8
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,252
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
38,252
Exercise price
$52.83
Footnotes
F9
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,423
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,423
Exercise price
Footnotes
F4, F7
TECH holding Derivative

Performance Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,945
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,945
Exercise price
$68.54
Footnotes
F7
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
51,890
Date
31 Jul 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
51,890
Exercise price
$68.54
Footnotes
F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Fully exercisable.

Footnote F2

Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.

Footnote F3

Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F5

Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F6

Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.

Footnote F7

Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F8

Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.

Footnote F9

Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.

Footnote F10

Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .